ASTRAZENECA CZECH REPUBLIC S.R.O. AND/ASupply Agreement • August 9th, 2022
Contract Type FiledAugust 9th, 2022This agreement (“Supply Agreement”) is made between: (1) (1) AstraZeneca Czech Republic s.r.o., having its registered seat at the address U Trezorky 921/2, Jinonice, 158 00 Praha 5, registered in the Commercial Register administered by the Municipal Court in Prague, Section C, Record 38105, Business ID No.: 639 84 482, Tax IN No.: CZ63984482, Bank details: CITIBANK Europe Plc, Bucharova 264/14, 158 02 Praha 5 Account No.:204 164 0206/2600, represented by Kuuno Vaher, executive (“AstraZeneca”); and Fakultní nemocnice Olomoucwith its registered office at I.P. Pavlova 185/6, 77900 Olomoucrepresented by: prof. MUDr. Roman Havlík, Ph.D., directorID No.: 00098892Tax ID No.: CZ00098892Bank connection: Česká národní banka (2) Account No.: 36334811/0710 (the“Purchaser”), (each a “Party”, and collectively the “Parties”). INTRODUCTION (A) AstraZeneca is actively pursuing the clinical development of the Product in order to file for and secure the Regulatory Approval before the Licensing Authority.
ASTRAZENECA CZECH REPUBLIC S.R.O. AND/ASupply Agreement • July 19th, 2022
Contract Type FiledJuly 19th, 2022
ASTRAZENECA CZECH REPUBLIC S.R.O. AND/ASupply Agreement • May 2nd, 2022
Contract Type FiledMay 2nd, 2022
ASTRAZENECA CZECH REPUBLIC S.R.O. AND/ASupply Agreement • April 22nd, 2022
Contract Type FiledApril 22nd, 2022
ASTRAZENECA CZECH REPUBLIC S.R.O. AND/ASupply Agreement • April 8th, 2022
Contract Type FiledApril 8th, 2022
ASTRAZENECA CZECH REPUBLIC S.R.O. AND/ASupply Agreement • March 25th, 2022
Contract Type FiledMarch 25th, 2022